Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension
Sympathetic renal denervation (RDN) has been demonstrated as a potential treatment option for patients with resistant hypertension [1]. Despite discouraging results after the SYMPLICITY HTN-3 trial several techniques and catheters were introduced to the market and data confirming adequate and effect...
Guardado en:
Autores principales: | Tomasz Tokarek, Renata Rajtar-Salwa, Łukasz Rzeszutko, Stanisław Bartuś |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67cdd25076de4cc0bf06f9a57988575e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The scope of sympathetic denervation in poliomyelitis
por: I. J. Zadikoff
Publicado: (1952) -
Joint ESH excellence centers' national meeting on renal sympathetic denervation: A Greek experts’ survey
por: Michael Doumas, et al.
Publicado: (2021) -
Renal artery denervation in patients with resistant arterial hypertension: clinical and organ-protective effect
por: Liudmila I. Gapon, et al.
Publicado: (2021) -
Effects of Renal Denervation on Cardiac Structural and Functional Abnormalities in Patients with Resistant Hypertension or Diastolic Dysfunction
por: Shiying Wang, et al.
Publicado: (2018) -
Acute renal denervation normalizes aortic function and decreases blood pressure in spontaneously hypertensive rats
por: Nathalia Juocys Dias Moreira, et al.
Publicado: (2020)